Buy Microsoft, Biogen for Performance, Avoid Consumer Discretionary Stocks

Posted on by

NEW YORK — It’s been a bumpy road for the S&P 500 this year but it has still churned out a 3% gain so far. […]

Read the original post by TheStreet.com